These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 15973527)

  • 21. Combination therapy in the treatment of persistent nocturnal enuresis.
    Cendron M; Klauber G
    Br J Urol; 1998 May; 81 Suppl 3():26-8. PubMed ID: 9634015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effectiveness of desmopressin in the treatment of childhood nocturnal enuresis: predicting response using pretreatment variables.
    Butler R; Holland P; Devitt H; Hiley E; Roberts G; Redfern E
    Br J Urol; 1998 May; 81 Suppl 3():29-36. PubMed ID: 9634016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Desmopressin tablet treatment in nocturnal enuresis.
    Stenberg A; Läckgren G
    Scand J Urol Nephrol Suppl; 1995; 173():95-9. PubMed ID: 8719577
    [No Abstract]   [Full Text] [Related]  

  • 24. Investigating the three systems approach to complex childhood nocturnal enuresis--medical treatment interventions.
    Butler RJ; Robinson JC; Holland P; Doherty-Williams D
    Scand J Urol Nephrol; 2004; 38(2):117-21. PubMed ID: 15204391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alarm treatment: influence on functional bladder capacity.
    Hansen AF; Jørgensen TM
    Scand J Urol Nephrol Suppl; 1997; 183():59-60. PubMed ID: 9165610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined treatment with enuresis alarm and desmopressin for nocturnal enuresis.
    Bradbury MG; Meadow SR
    Acta Paediatr; 1995 Sep; 84(9):1014-8. PubMed ID: 8652952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence against a synergistic effect of desmopressin with conditioning in the treatment of nocturnal enuresis.
    Gibb S; Nolan T; South M; Noad L; Bates G; Vidmar S
    J Pediatr; 2004 Mar; 144(3):351-7. PubMed ID: 15001941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nocturnal enuresis and daytime wetting: a multicentric trial with oxybutynin and desmopressin.
    Caione P; Arena F; Biraghi M; Cigna RM; Chendi D; Chiozza ML; De Lisa A; De Grazia E; Fano M; Formica P; Garofalo S; Gramenzi R; von Heland M; Lanza P; Lanza T; Maffei S; Manieri C; Merlini E; Miano L; Nappo S; Pagliarulo A; Paolini Paoletti F; Pau AC; Porru D; Artibani W
    Eur Urol; 1997; 31(4):459-63. PubMed ID: 9187908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Daytime functional bladder capacity as a predictor of response to desmopressin in monosymptomatic nocturnal enuresis.
    Eller DA; Austin PF; Tanguay S; Homsy YL
    Eur Urol; 1998; 33 Suppl 3():25-9. PubMed ID: 9599733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical inquiries. How effective is desmopressin for primary nocturnal enuresis?
    Diehr S; Scoville C; Bercaw DM
    J Fam Pract; 2003 Jul; 52(7):568-9. PubMed ID: 12841976
    [No Abstract]   [Full Text] [Related]  

  • 31. Prospective randomized trial using laser acupuncture versus desmopressin in the treatment of nocturnal enuresis.
    Radmayr C; Schlager A; Studen M; Bartsch G
    Eur Urol; 2001 Aug; 40(2):201-5. PubMed ID: 11528199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Canadian Enuresis Study and Evaluation--short- and long-term safety and efficacy of an oral desmopressin preparation.
    Wolfish NM; Barkin J; Gorodzinsky F; Schwarz R
    Scand J Urol Nephrol; 2003; 37(1):22-7. PubMed ID: 12745738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monosymptomatic primary enuresis: differences between patients responding or not responding to oral desmopressin.
    Medel R; Dieguez S; Brindo M; Ayuso S; Canepa C; Ruarte A; Podesta ML
    Br J Urol; 1998 May; 81 Suppl 3():46-9. PubMed ID: 9634019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination therapy for nocturnal enuresis.
    Butler RJ
    Scand J Urol Nephrol; 2001 Oct; 35(5):364-9. PubMed ID: 11771862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of nocturnal enuresis in children with desmopressin and bladder physiotherapy.
    Yannakoyorgos K; Ioannides E; Zahariou A; Anagnostopoulos D; Kasselas V; Kalinderis A
    Pediatr Surg Int; 1998 Apr; 13(4):281-4. PubMed ID: 9553190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of desmopressin on short-term memory in children with primary nocturnal enuresis.
    Müller D; Florkowski H; Chavez-Kattau K; Carlsson G; Eggert P
    J Urol; 2001 Dec; 166(6):2432-4. PubMed ID: 11696805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intermittent oral desmopressin therapy for monosymptomatic primary nocturnal enuresis.
    Akbal C; Ekici S; Erkan I; Tekgül S
    J Urol; 2004 Jun; 171(6 Pt 2):2603-6. PubMed ID: 15118429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term use and tapered dose reduction of intranasal desmopressin in the treatment of enuretic children.
    Riccabona M; Oswald J; Glauninger P
    Br J Urol; 1998 May; 81 Suppl 3():24-5. PubMed ID: 9634014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral and self-concept changes after six months of enuresis treatment: a randomized, controlled trial.
    Longstaffe S; Moffatt ME; Whalen JC
    Pediatrics; 2000 Apr; 105(4 Pt 2):935-40. PubMed ID: 10742350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nocturnal enuresis.
    Thiedke CC
    Am Fam Physician; 2003 Apr; 67(7):1499-506. PubMed ID: 12722850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.